A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Clinical trial NCT00601107 · COMPLETED

Trial details

NCT number: NCT00601107
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Chronic Plaque Psoriasis

Start date: 2008-04-01
Primary completion: 2009-02-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.